Health Trials

Genodermatosis

2

Review clinical trials related to Genodermatosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses

The goal of this clinical trial is to learn about deucravacitinib treatment in adults with inflammatory epidermal genodermatoses . The main question it aims to answer are: describe efficacity and safety of this treatment. Participants will take treatments and have to use bullets during the study period.

Participants needed: 10
Trial details
Phase: Phase 2Age: 18-99Biological sex: AllType: InterventionalSponsor: Centre Hospitalier Universitaire de NiceUpdated: Aug 5, 2025Locations: 2
Eligibility criteria

Subject has congenital skin fragility with skin and/or mucosal blisters, a clini... [+2]

Subjects with another form of ICI ie Netherton syndrome, Kid syndrome etc. [+2]

Read more
Status: Recruiting

A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized

The goal of this clinical trial is to Assessing the Efficacy and Safety of Apremilast in Patients \> 6 years of age with EB simplex generalized . The main question it aims to answer are: describe efficacity of this treatment. Participants will take treatments and have to use bullets during the study period.

Participants needed: 20
Trial details
Phase: Phase 2Age: 6-99Biological sex: AllType: InterventionalSponsor: Centre Hospitalier Universitaire de NiceUpdated: Feb 24, 2025Locations: 4
Eligibility criteria

Male or female patients 6 years or older [+3]

- EBS lesions requiring oral therapy to treat an infection [+4]

Read more